NL-OMON48886已完成不适用
Quality of life, cognitive function, and physical fitness of patients surviving more than 2 years after immune checkpoint inhibitor therapy - Quality of life and physical fitness after immune checkpoint inhibitors
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 195
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •1. Patient with melanoma, NSCLC or urogenital cancers *2 years since treatment
- •with at least one cycle of immune checkpoint inhibitor (CTLA-4 inhibitor,
- •PD(L)-1 inhibitor, or both) within the Department of Medical Oncology or
- •Pulmonary Oncology of the UMCG.
- •2. age *18 years at time of immune checkpoint inhibitor treatment
- •3. all previous or subsequent therapies allowed, including (brain) irradiation,
- •surgery for metastases, chemotherapy, and targeted therapy provided stable
- •clinical situation at time of inclusion
排除标准
- •1. switch of systemic therapy or local antitumor intervention (surgery,
- •radiotherapy) during last 2 months
- •2. inability to understand or abide to the study protocol
- •3. debilitating psychiatric illness
- •4. previous treatment for malignancy other than melanoma (excluding
- •non-melanoma skin cancer, cervical intra-epithelial neoplasia (CIN) or
- •carcinoma in situ of breast)
研究者
相似试验
招募中
不适用
Quality of Life and cognitive functioning in recently diagnosed TIA patientssmall stroke and transient ischaemic attack (TIA)10007963NL-OMON37095Onze Lieve Vrouwe Gasthuis100
招募中
不适用
Mental and physical quality of life and associated clinical parameters in patients with pituitary tumors: a questionnaire-based cross-sectional study (QoL pituitary)D35.2Pituitary glandDRKS00026950niversität Leipzig400
招募中
不适用
ong-term physical, cognitive and Quality-of-Life outcome and their risk factors in severe sepsisJPRN-UMIN000011036Division of Emergency Medicine, Tohoku University Graduate School of Medicine200
已完成
不适用
Cognitive functioning and health-related quality of life in long-term anaplastic oligondendroglioma and oligoastrocytoma survivors from the EORTC 26951 study: second follow-upoligondendroglioma/oligoastrocytomaprimary brain tumor10029211NL-OMON55406Haaglanden Medisch Centrum12
已完成
不适用
Physical and emotional well-being and cognitive functioning: the PREDICT-MR studyDepressionmood disorder. Cognitive impairment1002794610003216NL-OMON36665niversitair Medisch Centrum Utrecht250